期刊文献+

坦索罗辛对大鼠细菌性前列腺炎组织中左氧氟沙星药动学的影响 被引量:10

Influence of tamsulosin on the pharmacokinetics of levofloxacin in prostate of rats with bacterial prostatitis
下载PDF
导出
摘要 目的探讨坦索罗辛对急性细菌性前列腺炎模型大鼠前列腺组织中左氧氟沙星药动学的影响。方法将96只急性细菌性前列腺炎模型大鼠随机分为实验组(左氧氟沙星和坦索罗辛联合用药组)和对照组(单用左氧氟沙星组),每组48只,分别在给药后0.125、0.25、0.5、1、2、4、8和12h每个时间点处死6只大鼠,采集两组动物的前列腺制作组织匀浆,用HPLC法测定前列腺组织中左氧氟沙星浓度,3p97软件计算药动学参数。结果实验组和对照组药.时曲线均符合一室模型。主要药动学参数如下:t1/2分别为(4.78±0.75)h和(3.64±0.88)h,tpeak分别为(1.18±0.10)h和(O.81±0.29)h,Cmax分别为(6.16±0.57)μg/g和(3.91±0.62)gg/g,AUC0-12分别为(41.91±1.01)μg·h/g和(22.70±3.08)μg·h/g。结论坦索罗辛可以明显提高左氧氟沙星在急性细菌性前列腺炎模型大鼠前列腺组织中的药物浓度。 Objective To study the influence of tamsulosin on the pharmacokinetics of levofloxacin in prostate of model rats with acute bacterial prostatitis. Methods Ninty-six model rats with acute bacterial prostatitis were randomly divided into two groups: experimental group (both tamsulosin and levofloxacin were used, n=48) and control group (only levofloxacin was used, n=48). Six rats were sacrificed for collecting their prostatic samples to make tissue homogenate at each time point: 0.125, 0.25, 0.5, 1, 2, 4, 8 and 12h after drug administration. The levofloxacin concentrations were detected by HPLC and then pharmacokinetic parameters were calculated with 3p97 software program. Results The levofloxacin concentration-time curves of experimental group and control group were both fit the one-compartment model. The main pharmacokinetic parameters of the two groups as follows: t1/2 were (4.78±0.75)h and (3.64±0.88)h, tpeak were (1.18±0.10)h and (0.81±0.29)h, Cax were (6.16±0.57)μg/g and (3.91±0.62)μg/g, AUC0-12 were (41.91±1.01)μgh/g and (22.70±3.08)μgh/g, respectively. Conclusion Tamsulosin can obviously increase the concentration of levofloxacin in the prostate of model rats with acute bacterial prostatitis.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2013年第1期78-80,I0001,I0002,共5页 Chinese Journal of Antibiotics
关键词 坦索罗辛 左氧氟沙星 大鼠 细菌性前列腺炎 药代动力学 Tamsulosin Levofloxasin Rats Bacterial prostatitis Pharmacokinetics
  • 相关文献

参考文献12

  • 1Kreiger J N,Lee S W H,Jeon J. Epidemiology of prostatitis[J].International Journal of Antimicrobial Agents,2008,(Suppl 1):S85-S90.
  • 2Tripp DA,Nickel J C,Landist J R. Predictor of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome:finding from the National Institutes of Health Chronic Prostatitis cohort Study[J].British Journal of Urology,2004,(09):1279-1282.
  • 3Nickel J C,Downey J,Ardern D. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome[J].The Journal of Urology,2004,(02):551-554.
  • 4Anothaisintawee T,Attia J,Nickel J C. The management of chronic prostatitis/chronic pelvic pain syndrome:A systematic review and network metaanalysis[J].Journal of the American Medical Association,2011,(01):78-86.
  • 5Ye Z Q,Lan R Z,Yang W M. Tamsulosin Treatrnent of chronic non-bacterial prostatitis[J].Journal of International Medical Research,2008,(02):244-252.
  • 6Youn C W,Son K C,Choi H S. Comparison of the efficacy of antibiotic monotherapy and antibiotic plus alpha-blocker combination therapy for patients with inflammatory chronic prostatitis/chronic pelvic pain syndrome[J].Korean J Urol,2008,(01):72-76.
  • 7赵军,肖明朝,周远大,何海霞,曾洋.特拉唑嗪对左氧氟沙星在大鼠细菌性前列腺炎组织中分布的影响[J].中国新药与临床杂志,2010,29(3):199-202. 被引量:7
  • 8Elkahwaji J E,Ott C J,Janda L M. Mouse model for acute bacterial prostatitis in genetically distinct inbred strains[J].Urology,2005,(04):883-887.
  • 9徐淑云;卞如濂;陈修.药里实验方法学[M]北京:人民卫生出版社,2002202-204.
  • 10Schiller D S,Parikh A. Identification,pharmacologic considerations,and management of prostatitis[J].American Journal of Geriatric Pharmacotherapy,2011,(01):37-48.

二级参考文献9

共引文献6

同被引文献101

引证文献10

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部